216 related articles for article (PubMed ID: 25279712)
21. Malignant tumors with clear cell morphology: a comparative immunohistochemical study with renal cell carcinoma antibody, Pax8, steroidogenic factor 1, and brachyury.
Clayton EF; Ziober A; Yao Y; Bing Z
Ann Diagn Pathol; 2013 Apr; 17(2):192-7. PubMed ID: 23218904
[TBL] [Abstract][Full Text] [Related]
22. [Expression of CD10 and renal cell carcinoma marker in clear cell renal cell carcinoma: analysis on tissue arrays].
Ortiz-Rey JA; Gómez De María C; Peláez Boismorand E; Fernández Costas A; Barbosa Barreiro MJ; Antón Badiola I
Actas Urol Esp; 2006 Mar; 30(3):281-6. PubMed ID: 16749584
[TBL] [Abstract][Full Text] [Related]
23. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
24. Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma.
Butnor KJ; Nicholson AG; Allred DC; Zander DS; Henderson DW; Barrios R; Haque AK; Allen TC; Killen DE; Cagle PT
Arch Pathol Lab Med; 2006 Jun; 130(6):823-7. PubMed ID: 16740034
[TBL] [Abstract][Full Text] [Related]
25. Comparison of PAX-2, RCC antigen, and antiphosphorylated H2AX antibody (gamma-H2AX) in diagnosing metastatic renal cell carcinoma by fine-needle aspiration.
Wasco MJ; Pu RT
Diagn Cytopathol; 2008 Aug; 36(8):568-73. PubMed ID: 18618717
[TBL] [Abstract][Full Text] [Related]
26. PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: A comprehensive immunohistochemical study.
Zhai QJ; Ozcan A; Hamilton C; Shen SS; Coffey D; Krishnan B; Truong LD
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):323-32. PubMed ID: 20216401
[TBL] [Abstract][Full Text] [Related]
27. [Pax-2 antigen expression in kidney tumours].
Vjestica JM; Marković-Lipkovski J; Tulić CD; Djokić MR; Segar BS; Cirović SL; Stojanović MM; Vuksanović AM
Acta Chir Iugosl; 2011; 58(4):15-20. PubMed ID: 22519185
[TBL] [Abstract][Full Text] [Related]
28. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology.
Gokden N; Kemp SA; Gokden M
Diagn Cytopathol; 2008 Jul; 36(7):473-7. PubMed ID: 18528893
[TBL] [Abstract][Full Text] [Related]
29. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
Knoepp SM; Kunju LP; Roh MH
Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of morphologically unclassified renal cell carcinoma with electron microscopy and novel renal markers: implications for tumor reclassification.
Talento R; Hewan-Lowe K; Yin M
Ultrastruct Pathol; 2013 Feb; 37(1):70-6. PubMed ID: 23383617
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
Wiseman W; Michael CW; Roh MH
Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
[TBL] [Abstract][Full Text] [Related]
32. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
33. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.
Shen SS; Ro JY; Tamboli P; Truong LD; Zhai Q; Jung SJ; Tibbs RG; Ordonez NG; Ayala AG
Ann Diagn Pathol; 2007 Feb; 11(1):13-21. PubMed ID: 17240302
[TBL] [Abstract][Full Text] [Related]
34. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
Avery AK; Beckstead J; Renshaw AA; Corless CL
Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888
[TBL] [Abstract][Full Text] [Related]
35. Thyroid-like Follicular Carcinoma of the Kidney and Papillary Renal Cell Carcinoma with Thyroid-like Feature: Comparison of Two Cases and Literature Review.
Li C; Dong H; Fu W; Qi M; Han B
Ann Clin Lab Sci; 2015; 45(6):707-12. PubMed ID: 26663803
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry for the detection of renal cell carcinoma in effusion cytology.
Chute DJ; Kong CS; Stelow EB
Diagn Cytopathol; 2011 Feb; 39(2):118-23. PubMed ID: 21254459
[TBL] [Abstract][Full Text] [Related]
37. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.
Fan R
Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005
[TBL] [Abstract][Full Text] [Related]
38. PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.
Carney EM; Banerjee P; Ellis CL; Albadine R; Sharma R; Chaux AM; Burger PC; Netto GJ
Am J Surg Pathol; 2011 Feb; 35(2):262-7. PubMed ID: 21263247
[TBL] [Abstract][Full Text] [Related]
39. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.
Kuroda N; Agatsuma Y; Tamura M; Martinek P; Hes O; Michal M
Int J Clin Exp Pathol; 2015; 8(2):2131-8. PubMed ID: 25973115
[TBL] [Abstract][Full Text] [Related]
40. Co-Expression of Multiple
Li L; Li CG; Almomani SN; Hossain SM; Eccles MR
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]